Medtronic, Inc. (NYSE:MDT) agreed to sell its Physio-Control external defibrillator subsidiary to Bain Capital for roughly $478 million in cash.
"Medtronic expects to use a portion of the proceeds to offset any potential dilutive impact from this transaction to fiscal year 2012 non-GAAP earnings per share," the company said in a press release.
Stay tuned to MassDevice.com for more on this breaking story.
